相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of mitochondrial cardiolipin in heart function and its implication in cardiac disease
Jan Dudek et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models
Masaki Tokutome et al.
CARDIOVASCULAR RESEARCH (2019)
Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney
Cesar A. Romero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2019)
Unlockable Nanocomplexes with Self-Accelerating Nucleic Acid Release for Effective Staged Gene Therapy of Cardiovascular Diseases
Jing-Jun Nie et al.
ADVANCED MATERIALS (2018)
Vascular smooth muscle contraction in hypertension
Rhian M. Touyz et al.
CARDIOVASCULAR RESEARCH (2018)
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Steven J. Forrester et al.
CIRCULATION RESEARCH (2018)
Redox Regulation Beyond ROS: Why ROS Should Not Be Measured as Often
Ralf P. Brandes et al.
CIRCULATION RESEARCH (2018)
Strategies for the enhanced intracellular delivery of nanomaterials
Claudia Azevedo et al.
DRUG DISCOVERY TODAY (2018)
VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes
Karla B. Neves et al.
HYPERTENSION (2018)
Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults
Matthew J. Rossman et al.
HYPERTENSION (2018)
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Antonio Cuadrado et al.
PHARMACOLOGICAL REVIEWS (2018)
MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid β-Oxidation
Catherine A. Makarewich et al.
CELL REPORTS (2018)
Redox Regulation and Noncoding RNAs
Matthias S. Leisegang et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy
Umesh C. Sharma et al.
CIRCULATION-HEART FAILURE (2018)
Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH)
Anne-Catherine Pouleur et al.
ESC HEART FAILURE (2018)
Mitochondrial targeted peptides preserve mitochondrial organization and decrease reversible myocardial changes in early swine metabolic syndrome
Fang Yuan et al.
CARDIOVASCULAR RESEARCH (2018)
Therapeutic potential of NADPH oxidase 1/4 inhibitors
G. Teixeira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases
Jenny Y. Y. Ooi et al.
RNA BIOLOGY (2017)
Current perspectives in fragment-based lead discovery (FBLD)
Bas Lamoree et al.
STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY (2017)
Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increasesmyocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up
Juha Hartikainen et al.
EUROPEAN HEART JOURNAL (2017)
Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers
Tore Skotland et al.
EUROPEAN JOURNAL OF CANCER (2017)
The NRF2 activator DH404 attenuates adverse ventricular remodeling postmyocardial infarction by modifying redox signalling
Kristen J. Bubb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Redox modification of caveolar proteins in the cardiovascular system-role in cellular signalling and disease
Kristen J. Bubb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Placental Vesicles Carry Active Endothelial Nitric Oxide Synthase and Their Activity is Reduced in Preeclampsia
Carolina Motta-Mejia et al.
HYPERTENSION (2017)
Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease
Tetsuya Matoba et al.
JOURNAL OF CARDIOLOGY (2017)
Amelioration of atherosclerotic inflammation and plaques via endothelial adrenoceptor-targeted eNOS gene delivery using redox-sensitive polymer bearing L-arginine
Qurrat Ul Ain et al.
JOURNAL OF CONTROLLED RELEASE (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Redox Regulation of Inflammatory Processes Is Enzymatically Controlled
Inken Lorenzen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Chronic administration of mitochondrion-targeted peptide SS-31 prevents atherosclerotic development in ApoE knockout mice fed Western diet
Meng Zhang et al.
PLOS ONE (2017)
Mining for Micropeptides
Catherine A. Makarewich et al.
TRENDS IN CELL BIOLOGY (2017)
NOX Activation by Subunit Interaction and Underlying Mechanisms in Disease
Radhika Rastogi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Caveolin-1 scaffolding domain peptides enhance anti-inflammatory effect of heme oxygenase-1 through interrupting its interact with caveolin-1
Ping Weng et al.
ONCOTARGET (2017)
The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox
Demetrios Moris et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Challenges in the Development of Novel Cardiovascular Therapies
T. J. Hwang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease
Stephen P. Gray et al.
DIABETOLOGIA (2017)
Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease
Soni Deshwal et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium
Ehtesham Shafique et al.
CARDIOVASCULAR RESEARCH (2017)
Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure
B. Greenberg et al.
GENE THERAPY (2016)
P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1
Qiuxia Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association
Kathy K. Griendling et al.
CIRCULATION RESEARCH (2016)
RNA Therapeutics for Treatment of Cardiovascular Diseases Promises and Challenges
Tina Lucas et al.
CIRCULATION RESEARCH (2016)
Gene therapy for the treatment of heart failure: promise postponed
Jean-Sebastien Hulot et al.
EUROPEAN HEART JOURNAL (2016)
Redox signaling in the cardiomyocyte: From physiology to failure
Celio X. C. Santos et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
EFFECTS OF A NOVEL TETRAPEPTIDE IN HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF): A PHASE I RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ELAMIPRETIDE
Melissa A. Daubert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle
Benjamin R. Nelson et al.
SCIENCE (2016)
Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides
Douglas M. Anderson et al.
Science Signaling (2016)
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Eri H. Kobayashi et al.
NATURE COMMUNICATIONS (2016)
Widespread control of calcium signaling by a family of SERCA-inhibiting micropeptides
Douglas M. Anderson et al.
Science Signaling (2016)
Therapeutically targeting mitochondrial redox signalling alleviates endothelial dysfunction in preeclampsia
Cathal McCarthy et al.
SCIENTIFIC REPORTS (2016)
Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure
Hani N. Sabbah et al.
CIRCULATION-HEART FAILURE (2016)
CoQ10 Function and Role in Heart Failure and Ischemic Heart Disease
Anita Ayer et al.
ANNUAL REVIEW OF NUTRITION, VOL 35 (2015)
Antioxidants in Translational Medicine
Harald H. H. W. Schmidt et al.
ANTIOXIDANTS & REDOX SIGNALING (2015)
Fanning the flames: inflammation in cardiovascular diseases
Peter Libby
CARDIOVASCULAR RESEARCH (2015)
Initial Data Report from LARIAT: A Phase 2 Study of Bardoxolone Methyl in PAH Patients on Stable Background Therapy
Ronald Oudiz et al.
CHEST (2015)
Therapeutic Targeting of Autophagy Potential and Concerns in Treating Cardiovascular Disease
Amabel M. Orogo et al.
CIRCULATION RESEARCH (2015)
Coenzyme Q10 treatment of cardiovascular disorders of ageing including heart failure, hypertension and endothelial dysfunction
Yan-Kun Yang et al.
CLINICA CHIMICA ACTA (2015)
Redox biomarkers in cardiovascular medicine
Keyvan Karimi Galougahi et al.
EUROPEAN HEART JOURNAL (2015)
Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases
Luciano Cominacini et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Identification of Caveolar Resident Proteins in Ventricular Myocytes Using a Quantitative Proteomic Approach: Dynamic Changes in Caveolar Composition Following Adrenoceptor Activation
Krzysztof J. Wypijewski et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl
Melanie P. Chin et al.
AMERICAN JOURNAL OF NEPHROLOGY (2014)
Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts
Nina Kaludercic et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Redox regulation of endothelial cell fate
Ping Song et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Derivative of Bardoxolone Methyl, dh404, in an Inverse Dose-Dependent Manner Lessens Diabetes-Associated Atherosclerosis and Improves Diabetic Kidney Disease
Sih Min Tan et al.
DIABETES (2014)
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe -/- mice
E. Di Marco et al.
DIABETOLOGIA (2014)
Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl
Melanie P. Chin et al.
JOURNAL OF CARDIAC FAILURE (2014)
Monoamine oxidases as sources of oxidants in the heart
Nina Kaludercic et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy
Jay C. Jha et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS
Edward T. Chouchani et al.
NATURE (2014)
Therapeutic targeting of microRNAs: current status and future challenges
Zhonghan Li et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
Karina Huynh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Endothelial NADPH oxidases: which NOX to target in vascular disease?
Grant R. Drummond et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2014)
Glutathionylation Mediates Angiotensin II-Induced eNOS Uncoupling, Amplifying NADPH Oxidase-Dependent Endothelial Dysfunction
Keyvan Karimi Galougahi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Redox Modulation of Endothelial Nitric Oxide Synthase by Glutaredoxin-1 through Reversible Oxidative Post-Translational Modification
Chun-An Chen et al.
BIOCHEMISTRY (2013)
Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis
D. A. Lowes et al.
BRITISH JOURNAL OF ANAESTHESIA (2013)
Leptin promotes neointima formation and smooth muscle cell proliferation via NADPH oxidase activation and signalling in caveolin-rich microdomains
Marco R. Schroeter et al.
CARDIOVASCULAR RESEARCH (2013)
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus-Accelerated Atherosclerosis
Stephen P. Gray et al.
CIRCULATION (2013)
Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance-Related Endothelial Cell Dysfunction
Piruthivi Sukumar et al.
DIABETES (2013)
Monoamine Oxidases Are Mediators of Endothelial Dysfunction in the Mouse Aorta
Adrian Sturza et al.
HYPERTENSION (2013)
Selective Recapitulation of Conserved and Nonconserved Regions of Putative NOXA1 Protein Activation Domain Confers Isoform-specific Inhibition of Nox1 Oxidase and Attenuation of Endothelial Cell Migration
Daniel J. Ranayhossaini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation
Michelle E. Heid et al.
JOURNAL OF IMMUNOLOGY (2013)
Protein kinase-dependent oxidative regulation of the cardiac Na+-K+ pump: evidence from in vivo and in vitro modulation of cell signalling
Keyvan Karimi Galougahi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2013)
The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin
Alexander V. Birk et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I
Edward T. Chouchani et al.
NATURE MEDICINE (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Endothelial NADPH oxidase 2: when does it matter in atherosclerosis?
Judith Haendeler et al.
CARDIOVASCULAR RESEARCH (2012)
Redox Signaling in Cardiac Physiology and Pathology
Joseph R. Burgoyne et al.
CIRCULATION RESEARCH (2012)
Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease
Bor-Jen Lee et al.
NUTRITION (2012)
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function
Bianca C. Bernardo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All-Cause Mortality
Ali Abbasi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Enhancing Nrf2 Pathway by Disruption of Keap1 in Myeloid Leukocytes Protects against Sepsis
Xiaoni Kong et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Chronic Diseases: The Emerging Pandemic
Andre Terzic et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2011)
Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris
Narasimharajapura S. Rajendra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Grant R. Drummond et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARγ, and HO-1
Qing Qing Wu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Liposomal Antioxidants for Protection against Oxidant-Induced Damage
Zacharias E. Suntres
JOURNAL OF TOXICOLOGY (2011)
Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE(-/-) mice
Courtney P. Judkins et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury
Sang-Bing Ong et al.
CIRCULATION (2010)
Monoamine Oxidase A-Mediated Enhanced Catabolism of Norepinephrine Contributes to Adverse Remodeling and Pump Failure in Hearts With Pressure Overload
Nina Kaludercic et al.
CIRCULATION RESEARCH (2010)
Therapeutic Targeting of Mitochondrial Superoxide in Hypertension
Anna E. Dikalova et al.
CIRCULATION RESEARCH (2010)
The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients
Edward J. Gane et al.
LIVER INTERNATIONAL (2010)
A Double-Blind, Placebo-Controlled Study to Assess the Mitochondria-Targeted Antioxidant MitoQ as a Disease-Modifying Therapy in Parkinson's Disease
Barry J. Snow et al.
MOVEMENT DISORDERS (2010)
Heme oxygenase and renal disease
Tambi Jarmi et al.
CURRENT HYPERTENSION REPORTS (2009)
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide
Soona Shin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway
Wen Lin et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis
Damon A. Lowes et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant
Sabine Heumueller et al.
HYPERTENSION (2008)
Vitamins E and C in the Prevention of Cardiovascular Disease in Men The Physicians' Health Study II Randomized Controlled Trial
Howard D. Sesso et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition
Stavros Selemidis et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Anti-oxidant and anti-atherogenic properties of liposomal glutathione: Studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice
Rosenblat Mira et al.
ATHEROSCLEROSIS (2007)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel et al.
LANCET (2007)
Redox regulation of cardiac calcium channels and transporters
Aleksey V. Zima et al.
CARDIOVASCULAR RESEARCH (2006)
Reduced NAD(P)H oxidase in low renin hypertension - Link among angiotensin II, atherogenesis, and blood pressure
MS Zhou et al.
HYPERTENSION (2006)
Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury
P Bianchi et al.
CIRCULATION (2005)
Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury
VJ Adlam et al.
FASEB JOURNAL (2005)
Myeloperoxidase and cardiovascular disease
SJ Nicholls et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Regulation of Ca2+-induced permeability transition by Bcl-2 is antagonized by Drp1 and hFis1
DJ Kong et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis
VP Skulachev et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress
JS McNally et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Increased NADPH oxidase activity, gp91phox expression, and endothelium-dependent vasorelaxation during neointima formation in rabbits
TM Paravicini et al.
CIRCULATION RESEARCH (2002)
Glutamate-cysteine ligase modifier subunit:: mouse Gclm gene structure and regulation by agents that cause oxidative stress
WA Solis et al.
BIOCHEMICAL PHARMACOLOGY (2002)
The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis
S Frank et al.
DEVELOPMENTAL CELL (2001)
Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O2- and systolic blood pressure in mice
FE Rey et al.
CIRCULATION RESEARCH (2001)
Selective targeting of a redox-active ubiquinone to mitochondria within cells - Antioxidant and antiapoptotic properties
GF Kelso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin
JD Hayes et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2000)
分享论文
